Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription Articles published in Acta Ophthalmol Retrieve available abstracts of 52 articles: HTML format

Single Articles

May 2024
1. HATAMNEJAD A, Orr S, Dadak R, Khanani A, et al
   Anti-VEGF and steroid combination therapy relative to anti-VEGF mono therapy for the treatment of refractory DME: A systematic review of efficacy and meta-analysis of safety.
   Acta Ophthalmol. 2024;102:e204-e214.
   PubMed     Abstract available
   
   
   April 2024
2. SU ZZS, Ang BCH, Balne PK, Tun SBB, et al
   Effect of anti-VEGF on retinal blood flow in diabetic mice using laser speckle flowgraphy.
   Acta Ophthalmol. 2024 Apr 4. doi: 10.1111/aos.16672.
   PubMed     Abstract available
   
   
   March 2024
3. LINDBOE JB, Brynskov T, Sorensen TL, Schmidt Laugesen C, et al
   Real-world experiences with intravitreal treatment with ranibizumab and aflibercept for diabetic macular oedema 2008-2021.
   Acta Ophthalmol. 2024 Mar 25. doi: 10.1111/aos.16677.
   PubMed    
   
   
   
4. HELOTERA H, Arffman M, Sund R, Keskimaki I, et al
   The incidence and prevalence of diabetic macular edema and proliferative diabetic retinopathy, their progression to visual impairment and patterns in their intravitreal treatment in the Finnish population.
   Acta Ophthalmol. 2024 Mar 24. doi: 10.1111/aos.16675.
   PubMed     Abstract available
   
   
   February 2024
5. MABALA DS, Stokholm L, Andersen N, Andresen J, et al
   Diabetic retinopathy as an independent marker of cardiovascular disease in type 1 diabetes: Results from a nationwide longitudinal matched case-cohort study.
   Acta Ophthalmol. 2024 Feb 12. doi: 10.1111/aos.16653.
   PubMed     Abstract available
   
   
   
6. SHARIF A, Smith DR, Hellgren KJ, Jendle J, et al
   Diabetic retinopathy among the elderly with type 2 diabetes: A Nationwide longitudinal registry study.
   Acta Ophthalmol. 2024 Feb 10. doi: 10.1111/aos.16659.
   PubMed     Abstract available
   
   
   January 2024
7. BEK T, Andersen N, Andresen J, Grauslund J, et al
   Individualised screening for diabetic retinopathy with proliferative retinopathy and macular oedema as separate end points.
   Acta Ophthalmol. 2024 Jan 19. doi: 10.1111/aos.16637.
   PubMed     Abstract available
   
   
   December 2023
8. LOUKOVAARA S, Haukka J
   Incidence of diabetic macular oedema shows geographical regional differences in Finland-An epidemiological study.
   Acta Ophthalmol. 2023 Dec 29. doi: 10.1111/aos.16620.
   PubMed    
   
   
   
9. HUBER KL, Stino H, Schlegl T, Steiner I, et al
   Microaneurysm detection using high-speed megahertz optical coherence tomography angiography in advanced diabetic retinopathy.
   Acta Ophthalmol. 2023 Dec 21. doi: 10.1111/aos.16619.
   PubMed     Abstract available
   
   
   November 2023
10. GRAUSLUND J, Stokholm L, Andersen N, Andresen J, et al
    Risk of 2-year progression from no diabetic retinopathy to proliferative diabetic retinopathy in accordance with glycaemic regulation in 145 527 persons with diabetes in a national cohort.
    Acta Ophthalmol. 2023 Nov 10. doi: 10.1111/aos.15806.
    PubMed    
    
    
    
11. DRINKWATER JJ, Kalantary A, Turner AW
    A systematic review of diabetic retinopathy screening intervals.
    Acta Ophthalmol. 2023 Nov 1. doi: 10.1111/aos.15788.
    PubMed     Abstract available
    
    
    October 2023
12. CREUZOT GARCHER CP, Massin P, Srour M, Baudin F, et al
    Management of diabetic macular oedema in France from 2012 to 2018: The nationwide LANDSCAPE study.
    Acta Ophthalmol. 2023 Oct 24. doi: 10.1111/aos.15799.
    PubMed     Abstract available
    
    
    
13. DINESEN S, Stokholm L, Subhi Y, Henriksen JE, et al
    Retinal main vessel calibers and systemic markers for long-term development of proliferative diabetic retinopathy.
    Acta Ophthalmol. 2023 Oct 7. doi: 10.1111/aos.15780.
    PubMed     Abstract available
    
    
    
14. LOUKOVAARA S, Korhonen A, Niskanen L, Haukka J, et al
    Development of diabetic macular oedema shows associations with systemic medication - An epidemiological study.
    Acta Ophthalmol. 2023 Oct 3. doi: 10.1111/aos.15778.
    PubMed     Abstract available
    
    
    September 2023
15. HOLTZ JK, Thinggaard BS, Grauslund J, Subhi Y, et al
    Association between oral metformin use and the risk of age-related macular degeneration: A systematic review with meta-analysis.
    Acta Ophthalmol. 2023;101:595-605.
    PubMed     Abstract available
    
    
    August 2023
16. BEK T, Bech BH
    Visual acuity and causes of central visual loss in the adult Danish population 2020-2022. Results from the FORSYN study.
    Acta Ophthalmol. 2023;101:504-513.
    PubMed     Abstract available
    
    
    May 2023
17. MONESTAM EI
    Long-term results of cataract surgery in type 2 diabetics, a 20-year prospective longitudinal study.
    Acta Ophthalmol. 2023 May 4. doi: 10.1111/aos.15684.
    PubMed     Abstract available
    
    
    April 2023
18. THYKJAER AS, Andresen J, Andersen N, Bek T, et al
    Inter-grader reliability in the Danish screening programme for diabetic retinopathy.
    Acta Ophthalmol. 2023 Apr 17. doi: 10.1111/aos.15667.
    PubMed     Abstract available
    
    
    
19. NANJI K, Sarohia GS, Xie J, Patil NS, et al
    Anti-vascular endothelial growth factor therapy and retinal non-perfusion in diabetic retinopathy: A meta-analysis of randomised trials.
    Acta Ophthalmol. 2023 Apr 12. doi: 10.1111/aos.15673.
    PubMed     Abstract available
    
    
    March 2023
20. BAUMAL CR, Sorensen TL, Karcher H, Freitas RL, et al
    Efficacy and safety of brolucizumab in age-related macular degeneration: A systematic review of real-world studies.
    Acta Ophthalmol. 2023;101:123-139.
    PubMed     Abstract available
    
    
    
21. SCHMIDT MF, Christensen JL, Dahl VA, Toosy A, et al
    Automated detection of hyperreflective foci in the outer nuclear layer of the retina.
    Acta Ophthalmol. 2023;101:200-206.
    PubMed     Abstract available
    
    
    February 2023
22. JACOBA CMP, Salongcay RP, Aquino LAC, Salva CMG, et al
    Comparisons of handheld retinal imaging devices with ultrawide field images for determining diabetic retinopathy severity.
    Acta Ophthalmol. 2023 Feb 27. doi: 10.1111/aos.15651.
    PubMed     Abstract available
    
    
    
23. PEDERSEN FN, Stidsen JV, Rasmussen MN, Nielsen HB, et al
    Retinal microvascular markers in type 2 diabetes subphenotypes and latent autoimmune diabetes of adults.
    Acta Ophthalmol. 2023 Feb 7. doi: 10.1111/aos.15643.
    PubMed     Abstract available
    
    
    December 2022
24. SPERLING S, Stokholm L, Thykjaer AS, Pedersen FN, et al
    Bidirectional 5-year risks of diabetic retinopathy, glaucoma and/or ocular hypertension: Results from a national screening programme.
    Acta Ophthalmol. 2022 Dec 13. doi: 10.1111/aos.15300.
    PubMed     Abstract available
    
    
    
25. BRO T
    Worldwide ophthalmological research production 2000-2020, with special focus on the Nordic contribution.
    Acta Ophthalmol. 2022;100:e1760-e1766.
    PubMed     Abstract available
    
    
    October 2022
26. GRAUSLUND J, Pedersen FN, Andersen N, Andresen J, et al
    Presence and development of diabetic retinopathy in 153 238 patients with type 2 diabetes in the Danish Registry of Diabetic Retinopathy.
    Acta Ophthalmol. 2022 Oct 3. doi: 10.1111/aos.15264.
    PubMed     Abstract available
    
    
    September 2022
27. NANJI K, Khan M, Khalid MF, Xie JS, et al
    Treat-and-extend regimens of anti-vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta-analysis.
    Acta Ophthalmol. 2022;100:e1199-e1208.
    PubMed     Abstract available
    
    
    August 2022
28. VIRTANEN A, Haukka J, Loukovaara S, Harju M, et al
    Diabetes mellitus and risk of open-angle glaucoma-A population-based follow-up study.
    Acta Ophthalmol. 2022 Aug 23. doi: 10.1111/aos.15240.
    PubMed     Abstract available
    
    
    July 2022
29. OMARI A, Su L, Joltikov KA, Rao RC, et al
    Peripheral retinal dysfunction in diabetic macular edema.
    Acta Ophthalmol. 2022 Jul 28. doi: 10.1111/aos.15221.
    PubMed    
    
    
    
30. STEFANSSON E, Loftsson T, Larsen M, Papp A, et al
    Topical treatment of diabetic macular edema using dexamethasone ophthalmic suspension: A randomized, double-masked, vehicle-controlled study.
    Acta Ophthalmol. 2022 Jul 18. doi: 10.1111/aos.15215.
    PubMed     Abstract available
    
    
    June 2022
31. JORGENSEN MM, Vestergaard AH, Blindbaek SL, Peto T, et al
    Functional and structural efficacy of a novel combinational therapy of aflibercept and timely focal/grid photocoagulation in diabetic macular oedema: do clinical study results compare favourably with a standard-of-care treated real-world population?
    Acta Ophthalmol. 2022 Jun 8. doi: 10.1111/aos.15196.
    PubMed     Abstract available
    
    
    
32. BA-ALI S, Larsen M, Andersen HU, Lund-Andersen H, et al
    Full-field and multifocal electroretinogram in non-diabetic controls and diabetics with and without retinopathy.
    Acta Ophthalmol. 2022 Jun 3. doi: 10.1111/aos.15184.
    PubMed     Abstract available
    
    
    
33. PAN QT, Gao ZQ, Chen XH, Yang ZW, et al
    Outcomes of a novel bubble ultra-wide field viewing system for vitreoretinal surgery.
    Acta Ophthalmol. 2022;100:e1024-e1030.
    PubMed     Abstract available
    
    
    May 2022
34. MALERBI FK, Andrade RE
    Real-World diabetic retinopathy screening with a handheld fundus camera in a high-burden setting.
    Acta Ophthalmol. 2022 May 4. doi: 10.1111/aos.15170.
    PubMed    
    
    
    
35. HANSEN MS, Rasmussen M, Grauslund J, Subhi Y, et al
    Proteomic analysis of vitreous humour of eyes with diabetic macular oedema: a systematic review.
    Acta Ophthalmol. 2022 May 4. doi: 10.1111/aos.15168.
    PubMed     Abstract available
    
    
    April 2022
36. HERTZBERG SN, Moe MC, Jorstad OK, Petrovski BE, et al
    Healthcare expenditure of intravitreal anti-vascular endothelial growth factor inhibitors compared with dexamethasone implant for diabetic macular oedema.
    Acta Ophthalmol. 2022 Apr 25. doi: 10.1111/aos.15151.
    PubMed     Abstract available
    
    
    March 2022
37. ANDERSEN JKH, Hubel MS, Savarimuthu TR, Rasmussen ML, et al
    A digital online platform for education and certification of diabetic retinopathy health care professionals in the Region of Southern Denmark.
    Acta Ophthalmol. 2022 Mar 11. doi: 10.1111/aos.15123.
    PubMed     Abstract available
    
    
    
38. DAWSON VJ, Patnaik JL, Wildes M, Bonnell LN, et al
    Risk of posterior capsule rupture in patients with type 2 diabetes mellitus and diabetic retinopathy during phacoemulsification cataract surgery.
    Acta Ophthalmol. 2022 Mar 7. doi: 10.1111/aos.15121.
    PubMed    
    
    
    
39. BILLIOTI DE GAGE S, Bertrand M, Grimaldi S, Zureik M, et al
    Intravitreal anti-VEGF use in France: a cross-sectional and longitudinal Nationwide observational study.
    Acta Ophthalmol. 2022;100:e502-e511.
    PubMed     Abstract available
    
    
    
40. LOUKOVAARA S, Haukka J
    Cancer is associated with a 2.7 higher risk for intravitreal injection therapy in patients with age-related, diabetic, or vascular occlusive macular edema.
    Acta Ophthalmol. 2022;100:e609.
    PubMed    
    
    
    February 2022
41. SCHREUR V, Larsen MB, Sobrin L, Bhavsar AR, et al
    Imaging diabetic retinal disease: clinical imaging requirements.
    Acta Ophthalmol. 2022 Feb 9. doi: 10.1111/aos.15110.
    PubMed     Abstract available
    
    
    November 2021
42. KORHONEN A, Gucciardo E, Lehti K, Loukovaara S, et al
    Phosphodiesterase type 5 inhibitor (sildenafil) - impact in proliferative diabetic retinopathy?
    Acta Ophthalmol. 2021 Nov 8. doi: 10.1111/aos.15058.
    PubMed    
    
    
    October 2021
43. VEIBY NCBB, Simeunovic A, Heier M, Brunborg C, et al
    Retinal venular oxygen saturation is associated with non-proliferative diabetic retinopathy in young patients with type 1 diabetes.
    Acta Ophthalmol. 2021 Oct 20. doi: 10.1111/aos.15018.
    PubMed     Abstract available
    
    
    September 2021
44. DE CLERCK EEB, Schouten JSAG, Berendschot TTJM, Goezinne F, et al
    Vascular risk factors for optical coherence tomography-detected macular cysts: The Maastricht Study.
    Acta Ophthalmol. 2021;99:e860-e868.
    PubMed     Abstract available
    
    
    May 2021
45. VAN CRAENENDONCK T, Gerrits N, Buelens B, Petropoulos IN, et al
    Retinal microvascular complexity comparing mono- and multifractal dimensions in relation to cardiometabolic risk factors in a Middle Eastern population.
    Acta Ophthalmol. 2021;99:e368-e377.
    PubMed     Abstract available
    
    
    
46. BYBERG S, Vistisen D, Jorgensen ME, Diaz LJ, et al
    Quality assessment of a screening algorithm for diabetic retinopathy: prolongation of screening intervals with minimal effect of HbA1c and arterial hypertension on the length of intervals.
    Acta Ophthalmol. 2021;99:e360-e367.
    PubMed     Abstract available
    
    
    
47. WU Z, Liu B, Ma Y, Chen H, et al
    Discovery and validation of hsa_circ_0001953 as a potential biomarker for proliferative diabetic retinopathy in human blood.
    Acta Ophthalmol. 2021;99:306-313.
    PubMed     Abstract available
    
    
    
48. YU HS, Hong EH, Shin YU, Koh SH, et al
    ATP-binding cassette subfamily A-1 (ABCA1) levels are increased in the aqueous humour of proliferative diabetic retinopathy patients.
    Acta Ophthalmol. 2021;99:e442-e443.
    PubMed    
    
    
    March 2021
49. SHAN Y, Xu Y, Lin X, Lou L, et al
    Burden of vision loss due to diabetic retinopathy in China from 1990 to 2017: findings from the global burden of disease study.
    Acta Ophthalmol. 2021;99:e267-e273.
    PubMed     Abstract available
    
    
    
50. ZHANG K, Zhang S, Yu J, Lu Y, et al
    Changes of the tear film lipid layer thickness after cataract surgery in patients with diabetes mellitus.
    Acta Ophthalmol. 2021;99:e202-e208.
    PubMed     Abstract available
    
    
    
51. CAMPOS A, Campos EJ, Martins J, Ambrosio AF, et al
    The value of choroidal thickness in diabetic macular oedema is contradictory.
    Acta Ophthalmol. 2021;99:e281-e282.
    PubMed    
    
    
    
52. MATHIS T, Dot C, Mauget-Faysse M, Kodjikian L, et al
    Variation of choroidal thickness in diabetic macular edema: friend or foe?
    Acta Ophthalmol. 2021;99:e282-e283.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.